MXRA5 and non-small cell lung carcinoma: The MXRA5 protein is aberrantly expressed in non-small-cell lung carcinoma (NSCLC), and a high MXRA5 expression is correlated with tumor progression and overall survival, indicating its potential value as a novel therapeutic target for the treatment of NSCLC [18].